Assess the Safety, Pharmacokinetics, Pharmacodynamics and Clinical Activity of RXC007 in Idiopathic Pulmonary Fibrosis

NCT05570058 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

IPF
Fibrosis

Interventions

DRUG: RXC007
DRUG: Placebo

Sponsor

Redx Pharma Ltd

Collaborators

[object Object]